MIRA INFORM REPORT

 

 

Report Date :

04.10.2012

 

IDENTIFICATION DETAILS

 

Name :

ALVOGEN FARMA TREYDING YURAP EOOD

 

 

Registered Office :

 

J.K. Manastirski livadi - Zapad, bul. Bulgaria No.86, et.1 1680 Sofia

 

 

 

 

Country :

Bulgaria

 

 

 

 

Financials (as on) :

31.12.2011

 

 

 

 

Year of Establishment :

2011

 

 

 

 

Legal Form :

Sole Proprietor Limited Liability Company (EOOD)

 

 

 

 

Line of Business :

Wholesale of pharmaceutical goods

 

 

 

 

No. of Employees :

17

 

 

 

RATING & COMMENTS

 

MIRA’s Rating :

NB

 

RATING

STATUS

PROPOSED CREDIT LINE

--

NB

New Business

 

--

 

Status :

New Company

Payment Behaviour :

Unknown

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

 

Country Name

Previous Rating

(31.03.2011)

Current Rating

(30.06.2012)

Bulgaria

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

BULGARIA - ECONOMIC OVERVIEW

 

Bulgaria, a former Communist country that entered the EU on 1 January 2007, averaged more than 6% annual growth from 2004 to 2008, driven by significant amounts of bank lending, consumption, and foreign direct investment. Successive governments have demonstrated a commitment to economic reforms and responsible fiscal planning, but the global downturn sharply reduced domestic demand, exports, capital inflows, and industrial production. GDP contracted by 5.5% in 2009, stagnated in 2010, despite a significant recovery in exports, and grew approximately 2.2% in 2011. Despite having a favorable investment regime, including low, flat corporate income taxes, significant challenges remain. Corruption in public administration, a weak judiciary, and the presence of organized crime continue to hamper the country's investment climate and economic prospects.

Source : CIA


COMPANY DETAILS

 

Local name: ALVOGEN FARMA TREYDING YURAP EOOD

International name: ALVOGEN PHARMA TRADING EUROPE EOOD

 

Registered address:

j.k. Manastirski livadi - Zapad, bul. Bulgaria No.86, et.1
1680 Sofia
Bulgaria
Telephone: +359-2/441 71 36
Fax: +359-2/441 71 39
E-Mail: info.bulgaria@alvogen.com
Internet: http://www.alvogen.com

 

ESTABLISHMENT & REGISTRATION:

Established:                  2011
Registered at                 Bulgarian trade register
Court number                 201400639
Bulstat/VAT number:      201400639

 

LEGAL FORM:

Sole Proprietor Limited Liability Company (EOOD)

 

REGISTERED CAPITAL:

BGN 5 000.00

 

 

SHAREHOLDERS/MANAGEMENT

 

SHAREHOLDERS:

ALVOGEN CEE Kft. (Hungary) - 100%

 

MANAGEMENT:

PETAR ANTONOV VAJAROV - manager
KORNELIU LORENTIU SKEUSAN - manager

 

RELATED COMPANIES:

none

 

 

BUSINESS ACTIVITY

 

BUSINESS OPERATION:

NACE 1.1: 51.46 Wholesale of pharmaceutical goods

 

Activity:

Trade and marketing of pharmaceutical products.

 

NUMBER OF EMPLOYEES:

 

As at date

Value

Latest stand

17

 

EXPORT:

None

 

IMPORT:

EU

 

REAL ESTATE:

None

 

 

FINANCIAL DATA

 

TURNOVER:

 

Year

Currency

Value

2011

BGN

3 059 000.00


turnover

MODES OF PAYMENT:

Payments are not always regular.

 

DEBT COLLECTION:

No debt collection cases are registered against the company.

 

BANK DISTRAINTS:

No shares of the company are under bank distraint.

 


UNPAID TAXES/ CONTRIBUTIONS TO GOVERNMENT:

There is no publication about overdue unpaid taxes.

 

INVOLVEMENT IN LEGAL DISPUTES:

There is no publication about legal claims or disputes against the company.

 

OTHER PAYMENT INFORMATION:

No adverse payment information is available.

 

BRANCH INDICATOR:

The company's payment behaviour is slower than average for the branch.

 

Exchange since for 1998 BGN (denominated lev) = 0.51 EUR

 

Ratio

2011

Debt ratio

1.35

Quick ratio

1.07

Current ratio

1.21

Days purchase in payables

308.45

Operating margin in %

0.00

Cash ratio (acid ratio)

0.02

Return on sales ROS in %

0.00

Return on assets ROA in %

0.00

Return on equity ROE in %

0.00

Days supply in inventory

41.19

Days sales in receivables

323.52

 

 

BALANCE SHEET in BGN'000

2011

Accounting period:

1.1.2011 -
31.12.2011

A.UNPAID CAPITAL

 

B. FIXED ASSETS

 

I Fixed Intangible Assets:

 

R&D Products

 

Concessions, patents, trade-marks etc

5

Goodwill

 

Intangible fixed assets under construction

13

thereof advances

 

Total I:

18

II Fixed Tangible Assets

 

Land and Buildings

 

thereof Land

 

thereof Buildings

 

Machines, Vehicles

11

Equipment

194

Tangible fixed assets under construction

 

thereof advances

 

Total II

205

III. Fixed Financial Assets

 

Shares in group companies

 

Loans granted to group companies

 

Shares in joint ventures

 

Long term investments

 

Other loans

 

Bought back own shares

 

Total III

 

IV. Deferred Taxes

137

B. FIXED ASSETS TOTAL

360

C. CURRENT ASSETS

 

I. Inventories

 

Raw Materials

 

Work in progress

 

thereof young animals

 

Trading goods

350

thereof production

 

thereof goods for sale

350

Advances

 

Total I

350

II. Receivables

 

Receivables from customers

2694

thereof more than 1 year

 

Receivables from group companies

 

thereof more than 1 year

 

Receivables from joint ventures

 

thereof more than 1 year

 

Other receivables

55

thereof more than 1 year

 

Total II

2749

III. Current Financial Assets

 

Current investments in related companies

 

Bought back own shares

 

Other current financial assets

 

Total III

 

IV. Cash equivalents

 

Cash and accounts in the country

60

thereof cash

 

Thereof cash in foreign currency (equivalent)

 

thereof current accounts

60

thereof blocked accounts

 

thereof cash equivalents

 

Cash and accounts abroad

 

thereof cash

 

Thereof cash in foreign currency (equivalent)

 

thereof current accounts

 

thereof blocked accounts

 

Total IV

60

C. CURRENT ASSETS TOTAL

3159

D. Deferred expenses

8

TOTAL ASSETS

3527

A. OWNERS EQUITY

 

I. Share capital

5

II. Issue premium

 

III. Revaluation reserves

 

thereof revaluation reserves of financial instruments

 

IV. Reserves

 

legal reserves

 

reserve related to bought back own shares

 

reserve from company foundation

 

other reserves

 

Total IV

 

V. Result from previous period

 

Undistributed profit

 

Uncovered loss

 

Total V

 

VI. Current result profit (loss)

-1256

A. OWNERS EQUITY TOTAL

-1251

B. PROVISIONS

 

Provisions for pensions

 

Provisions for taxes

 

thereof deferred taxes

 

Other provisions

 

B. PROVISIONS TOTAL

 

C. LIABILITIES

 

Bond-backed loans

 

less than 1 year

 

more than 1 year

 

Bank loans

135

less than 1 year

 

more than 1 year

135

Advances received

 

less than 1 year

 

more than 1 year

 

Payables to suppliers

2209

less than 1 year

2209

more than 1 year

 

Liabilities on policies

 

less than 1 year

 

more than 1 year

 

Liabilities to group companies

2022

less than 1 year

 

more than 1 year

2022

Liabilities to joint-venture companies

 

less than 1 year

 

more than 1 year

 

Other liabiliies

412

less than 1 year

412

more than 1 year

 

thereof to personnel

16

less than 1 year

16

more than 1 year

 

thereof to social insurance

2

less than 1 year

2

more than 1 year

 

thereof for taxes

 

less than 1 year

 

more than 1 year

 

C. LIABILITIES TOTAL

4778

less than 1 year

2621

more than 1 year

2157

D. FINANCING AND DEFERRED INCOME

 

thereof

 

Financing

 

Deferred income

 

TOTAL EQUITY AND LIABILITIES

3527

 

 

P&L ACCO

UNT in BGN'000

2011

Accounting period:

1.1.2011 -
31.12.2011

A. EXPENSES

 

I. OPERATION EXPENSES

 

Decrease of inventories

 

thereof for materials

7

thereof for services

566

Personnel expenses

713

thereof wages

684

thereof social insurance

29

thereof pensions

24

Depreciation

11

thereof Depreciation of fixed assets

11

Other expenses

3017

thereof Book value of sold assets (without production)

2798

I. OPERATION EXPENSES TOTAL

4314

II. Financial expenditures

 

Depreciation of financial assets

182

thereof exchange rate losses

182

Paid interest

24

thereof interest to group companies

 

Thereof expenditures for securities operations

 

II. Financial expenditures Total

206

B. Profit on ordinary activity

 

III. Extraordinary expenses

 

thereof expenses on disasters and emergency expenses

 

C. Total expenses (I+II+III)

4520

D. Accounting profit

 

IV. Taxation on profit

-136

V. Other taxes

 

E. Net profit

 

Total expenses

4384

A. REVENUES

 

I . OPERATING REVENUES

 

Net sales

3059

Production

 

Goods

3059

Services

 

Increase of production and work in progress

 

Expenses on acquisition of assets

 

Other revenues

 

thereof financing

 

I. TOTAL OPERATING REVENUES

3059

II FINANCIAL REVENUES

 

Income from shares

 

thereof income from shares in group companies

 

Income from investments and loans

 

thereof from investments in group companies

 

Income from interest

 

thereof from interest from group companies

 

II FINANCIAL REVENUES TOTAL

68

TOTAL REVENUES FROM ORDINARY ACTIVITIES

3127

LOSS

1256

Extraordinary revenues

 

AFTER TAX LOSS

1256

TOTAL REVENUES

4384

 

Позвъни

Прати SMS

Добавяне в Skype

Необходим е Skype кредитБезплатно по Skype

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.52.33

UK Pound

1

Rs.84.30

Euro

1

Rs.67.45

 

 

INFORMATION DETAILS

 

Report Prepared by :

PRL

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.